In Reply:
We thank Doctor Rupp for his interest in our article and take the opportunity to answer his questions. In the normotensive population, 24-h ambulatory blood pressure values are lower than those obtained in the office. Therefore, the threshold for definition of hypertension is lower than for office readings: 125/80 mm Hg. 1 According to this definition, 18 of the 27 subjects that completed the study have to be considered as being hypertensive. Thus, it is not justified to regard the study population as being normotensive. The rationale of excluding moderate and severe forms of hypertension from our study is given in the last paragraph of the introduction.
In our study, eprosartan lead to significant increases in both sympathetic vasoconstrictor outflow to skeletal muscle vasculature and plasma norepinephrine levels (Fig. 2B of the original article). Hence, there is no convincing reason to assume that eprosartan inhibits the release of norepinephrine from sympathetic terminals in the study population. Because the methodology of measuring plasma levels for quantification of norepinephrine release is feeble, we cast into doubt this feature of eprosartan rather than rejecting it completely. We cannot exclude that there is a certain dampening of norepinephrine release, as we stated in the Limitations section. Moreover, relevant references arguing in favor of [2] [3] [4] and against this view 5 had been included in the original article. As expected, mental stress resulted in a significant elevation of heart rate in both conditions (eprosartan: ϩ12 beats/min; placebo: ϩ15 beats/min); however, the stressinduced increase was significantly smaller with eprosartan. Because angiotensin II increases with mental stress and it has cardio-accelerating effects in dogs that are independent of the adrenergic system, 6 AT1 antagonism could reduce the increase in heart rate provoked by mental stress. Moreover, Barki-Harrington et al 7 have shown that the AT1
